dihydroergotamine has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiedler, VB; Göbel, H; Nitz, RE | 1 |
| Oloff, SH | 1 |
| Borris, LC; Christiansen, HM; Knudsen, VE; Lassen, MR; Møller-Larsen, F; Nielsen, BW | 1 |
1 trial(s) available for dihydroergotamine and Cardiovascular Diseases
| Article | Year |
|---|---|
A synopsis of the therapeutic trials of amezinium.
Topics: 2-Hydroxyphenethylamine; Cardiovascular Diseases; Clinical Trials as Topic; Dihydroergotamine; Hemodynamics; Humans; Hypotension; Octopamine; Pyridazines | 1981 |
2 other study(ies) available for dihydroergotamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of dihydroergotamine on hemodynamic molsidomine actions in anesthetized dogs.
Topics: Anesthesia; Animals; Cardiac Output; Cardiovascular Diseases; Dihydroergotamine; Dogs; Drug Interactions; Female; Hemodynamics; Male; Molsidomine; Oxadiazoles; Stroke Volume; Sydnones; Time Factors | 1984 |
[Circulatory insufficiency during prevention of thrombosis with heparin/dihydroergotamine. Effect or side-effect?].
Topics: Aged; Cardiovascular Diseases; Dihydroergotamine; Female; Heparin; Humans; Leg; Male; Middle Aged; Thrombosis | 1988 |